{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:08:02Z","timestamp":1790788082953,"version":"4.1.0"},"reference-count":28,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:p>Monogenic obesity generally results in severe early-onset obesity associated with abnormal feeding behavior and endocrine disorders. We report here an extremely severe case of early-onset obesity associated with hyperphagia in an 11-month-old boy without other signs of a syndromic obesity. He developed severe obstructive sleep apnea, dyslipidemia, hepatic steatosis with cytolysis, and acanthosis nigricans with insulin resistance in the first months of life. Laboratory investigations showed an elevated serum leptin level (80.03 ng\/mL, normal range 2.45\u20136.55 ng\/mL). Next-generation sequencing of obesity genes panel identified a novel homozygous intronic variant in leptin receptor gene (LEPR), c.703\u2009+\u20095G&amp;gt;A, predicting affected splicing that resulted in a frameshift, premature stop, and truncation of the protein beyond the cytokine receptor homology domain 1. The child died at 27 months of age in the absence of available specific drug therapy.<\/jats:p>","DOI":"10.1542\/peds.2022-059569","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T08:12:49Z","timestamp":1688026369000},"source":"Crossref","is-referenced-by-count":7,"title":["A Novel Leptin Receptor <i>LEPR<\/i> Variant in a Toddler With Early-Onset Fatal Obesity"],"prefix":"10.1542","volume":"152","author":[{"given":"Kevin","family":"Perge","sequence":"first","affiliation":[{"name":"aH\u00f4pital Femme M\u00e8re Enfant, Service d\u2019Endocrinologie P\u00e9diatrique et P\u00e9diatrie G\u00e9n\u00e9rale, Hospices Civils de Lyon, Bron, France"},{"name":"bUniversit\u00e9 Claude Bernard, Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Pons","sequence":"additional","affiliation":[{"name":"cUnit\u00e9 Fonctionnelle de Cytog\u00e9n\u00e9tique, Laboratoire de Biologie M\u00e9dicale, Centre hospitalier de Valence, Valence, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastassja","family":"Protsenko","sequence":"additional","affiliation":[{"name":"dHospices Civils de Lyon, DIAB-eCARE Diabetes Center, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Collin-Chavagnac","sequence":"additional","affiliation":[{"name":"eGroupement Hospitalier Sud, Service de biochimie et biologie mol\u00e9culaire, Hospices civils de Lyon, Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Nicolino","sequence":"additional","affiliation":[{"name":"aH\u00f4pital Femme M\u00e8re Enfant, Service d\u2019Endocrinologie P\u00e9diatrique et P\u00e9diatrie G\u00e9n\u00e9rale, Hospices Civils de Lyon, Bron, France"},{"name":"bUniversit\u00e9 Claude Bernard, Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"2023111414262879800_B1","unstructured":"Obesity and overweight. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. Accessed January 31, 2023"},{"issue":"2","key":"2023111414262879800_B2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/obr.12625","article-title":"On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations","volume":"19","author":"Qasim","year":"2018","journal-title":"Obes Rev"},{"issue":"3","key":"2023111414262879800_B3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000445061","article-title":"Rare genetic forms of obesity: clinical approach and current treatments in 2016","volume":"9","author":"Huvenne","year":"2016","journal-title":"Obes Facts"},{"issue":"1","key":"2023111414262879800_B4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cne.20786","article-title":"Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis","volume":"493","author":"Elmquist","year":"2005","journal-title":"J Comp Neurol"},{"issue":"1","key":"2023111414262879800_B5","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-18-0596","article-title":"The melanocortin pathway and control of appetite-progress and therapeutic implications","volume":"241","author":"Baldini","year":"2019","journal-title":"J Endocrinol"},{"issue":"3","key":"2023111414262879800_B6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","article-title":"Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist","volume":"375","author":"K\u00fchnen","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"2023111414262879800_B7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","article-title":"MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency","volume":"24","author":"Cl\u00e9ment","year":"2018","journal-title":"Nat Med"},{"issue":"12","key":"2023111414262879800_B8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2023111414262879800_B9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s13300-020-00816-y","article-title":"Drug therapy in obesity: a review of current and emerging treatments","volume":"11","author":"Williams","year":"2020","journal-title":"Diabetes Ther"},{"key":"2023111414262879800_B10","doi-asserted-by":"crossref","first-page":"113134","DOI":"10.1016\/j.physbeh.2020.113134","article-title":"Rare genetic forms of obesity: from gene to therapy","volume":"227","author":"Cl\u00e9ment","year":"2020","journal-title":"Physiol Behav"},{"issue":"9","key":"2023111414262879800_B11","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41366-018-0049-6","article-title":"Early childhood BMI trajectories in monogenic obesity due to leptin, leptin receptor, and melanocortin 4 receptor deficiency","volume":"42","author":"Kohlsdorf","year":"2018","journal-title":"Int J Obes"},{"issue":"3","key":"2023111414262879800_B12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6704","key":"2023111414262879800_B13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"issue":"10","key":"2023111414262879800_B14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tem.2003.10.003","article-title":"The role of leptin receptor signaling in feeding and neuroendocrine function","volume":"14","author":"Bates","year":"2003","journal-title":"Trends Endocrinol Metab"},{"issue":"6674","key":"2023111414262879800_B15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Cl\u00e9ment","year":"1998","journal-title":"Nature"},{"issue":"3","key":"2023111414262879800_B16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa063988","article-title":"Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor","volume":"356","author":"Farooqi","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"2023111414262879800_B17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/js.2018-00123","article-title":"Functional and phenotypic characteristics of human leptin receptor mutations","volume":"3","author":"Nunziata","year":"2018","journal-title":"J Endocr Soc"},{"issue":"1","key":"2023111414262879800_B18","doi-asserted-by":"crossref","first-page":"e12574","DOI":"10.1111\/ijpo.12574","article-title":"Monogenic leptin deficiency in early childhood obesity","volume":"15","author":"ElSaeed","year":"2020","journal-title":"Pediatr Obes"},{"issue":"8","key":"2023111414262879800_B19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/diabetes.49.8.1347","article-title":"Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass","volume":"49","author":"Lahlou","year":"2000","journal-title":"Diabetes"},{"issue":"5","key":"2023111414262879800_B20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4274\/jcrpe.v1i5.233","article-title":"The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome","volume":"1","author":"Alika\u015fifo\u011flu","year":"2009","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2023111414262879800_B21","doi-asserted-by":"crossref","first-page":"bcr2017221067","DOI":"10.1136\/bcr-2017-221067","article-title":"Young girl with severe early-onset obesity and hyperphagia","volume":"2017","author":"Kleinendorst","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"8","key":"2023111414262879800_B22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"issue":"6","key":"2023111414262879800_B23","doi-asserted-by":"crossref","first-page":"bvac057","DOI":"10.1210\/jendso\/bvac057","article-title":"Natural history of obesity due to POMC, PCSK1, and LEPR deficiency and the impact of setmelanotide","volume":"6","author":"Wabitsch","year":"2022","journal-title":"J Endocr Soc"},{"key":"2023111414262879800_B24","doi-asserted-by":"crossref","first-page":"154438","DOI":"10.1016\/j.metabol.2020.154438","article-title":"Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity","volume":"116","author":"Voigtmann","year":"2021","journal-title":"Metabolism"},{"issue":"3","key":"2023111414262879800_B25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40265-021-01470-9","article-title":"Setmelanotide: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"issue":"9","key":"2023111414262879800_B26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMc2207442","article-title":"Long-term MC4R agonist treatment in POMC-deficient patients","volume":"387","author":"K\u00fchnen","year":"2022","journal-title":"N Engl J Med"},{"key":"2023111414262879800_B27","unstructured":"Rhythm Pharmaceuticals, Inc\n          . A phase 3, randomized, double-blind, placebo-controlled study: 5 independent sub-studies of setmelanotide in patients with POMC, PCSK1, LEPR, SRC1, SH2B1, or PCSK1 N221D gene defects in the melanocortin-4 receptor pathway. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05093634. Accessed January 31, 2023"},{"issue":"1","key":"2023111414262879800_B28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/EJE-19-0678","article-title":"Leptin receptor deficiency: a systematic literature review and prevalence estimation based on population genetics","volume":"182","author":"Kleinendorst","year":"2020","journal-title":"Eur J Endocrinol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2022-059569\/1566774\/peds_2022059569.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2022-059569\/1566774\/peds_2022059569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T14:27:34Z","timestamp":1699972054000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/152\/1\/e2022059569\/192428\/A-Novel-Leptin-Receptor-LEPR-Variant-in-a-Toddler"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,29]]},"published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2022-059569","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"e2022059569"}}